Parexel International - Baltimore Early Phase Clinical Unit — Baltimore, Maryland

Parexel International - Baltimore Early Phase Clinical Unit is a clinical research site located in Baltimore, Maryland, United States 21225.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Parexel International - Baltimore Early Phase Clinical Unit has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Healthy Subjects, Exosome, Targeted Therapy.

Sponsors: Shine-On Biomedical Co., Ltd..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Parexel International - Baltimore Early Phase Clinical Unit?

Parexel International - Baltimore Early Phase Clinical Unit has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Parexel International - Baltimore Early Phase Clinical Unit conducted?

Parexel International - Baltimore Early Phase Clinical Unit has 1 clinical trials on record, with 1 currently active. Their work covers Healthy Subjects, Exosome, Targeted Therapy.

Is Parexel International - Baltimore Early Phase Clinical Unit accredited by Crixeo Health?

Parexel International - Baltimore Early Phase Clinical Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Parexel International - Baltimore Early Phase Clinical Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.